Friday 6 November 2026 Export CYTK’s income statement to Excel — free account

Cytokinetics, Incorporated

Cytokinetics, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $88.0 million, up 376.6% from fiscal 2024.

Revenue: +2,356.5%
EPS: +46.4%
Free cash flow: −6.73%
Total debt: +6.01%

Quarter to September 2026, against a year earlier

53.84 1.71 −3.08%

Follow CYTK

Alert me

Market cap: $7.7B
P/E: 0.0×
Fwd P/E: −10.3×
Dividend yield: —
F-score: 2/9
Altman Z: −1.98
Beneish M: −0.44
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	2	1	4
ROE Full definition →		197.47%	151.81%	329.76%	184.71%
ROA Full definition →		(55.55%)	(65.39%)	(56.76%)	(47.70%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(98.90%)	(114.79%)	(80.83%)	(85.50%)
Average Days of Receivables Full definition →		73.65	23.55	131.78	109.18
Free Cash Flow per Share Full definition →		(4.45)	(4.45)	(4.40)	(4.23)
Free Cash Flow Full definition →		(534.82)	(548.92)	(580.71)	(588.58)
Capital Expenditures Full definition →		(24.81)	(25.07)	(25.26)	(16.61)
Other line items
Cash ROIC Full definition →		(38.76%)	(47.55%)	(27.15%)	(30.02%)
Accounts Receivable Turnover Full definition →		5.12	23.94	4.12	6.35
Accounts Payable Turnover Full definition →		0.00	0.44	0.68	0.51
Inventory Turnover Full definition →		—	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	1,063.16	599.08	770.73
Days of Inventory on Hand Full definition →		—	6.63	11.10	23.96
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		472.55%	390.58%	592.52%	355.67%
Selling, General and Administrative Expense of Revenue Full definition →		322.89%	313.56%	547.47%	365.57%
Share Based Compensation of Revenue Full definition →		127.54%	112.58%	188.13%	115.92%
Interest Coverage Full definition →		(5.89)	(5.60)	(5.67)	(5.17)
Operating CF/Net income Full definition →		0.65	0.63	0.62	0.74
Depreciation/Fixed assets Full definition →		0.13	0.14	0.16	0.18
Capex/Depreciation Full definition →		(2.45)	(2.24)	(2.01)	(1.23)
Revenue per Share Full definition →		0.73	0.86	0.51	0.81
Operating CF per Share Full definition →		(4.25)	(4.25)	(4.21)	(4.11)
Capex per Share Full definition →		(0.21)	(0.20)	(0.19)	(0.12)
Capex to Sales Full definition →		0.28	0.24	0.37	0.15

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly